The India Urology Devices Market was valued at $813.9 Million in 2025 and projected to reach to $1227.7 Million by 2030, representing a compound annual growth rate of 8.6%. India's urology devices market is poised for sustained growth, supported by a rising disease burden, expanding middle-class population, and increasing healthcare accessibility.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India's urology devices market is projected to grow from USD 813.9 million in 2025 to USD 1,227.7 million by 2030, driven by increasing healthcare investments and rising patient awareness across metropolitan and tier-2 cities.
Growing prevalence of kidney stones, benign prostatic hyperplasia, and urinary tract infections in India is fueling demand for advanced diagnostic and therapeutic urology devices among both public and private healthcare facilities.
Indian hospitals and clinics are increasingly adopting minimally invasive urological procedures, including endoscopic and laser-based treatments, supported by improving healthcare infrastructure in urban and semi-urban regions.
Schemes like Ayushman Bharat and increased public health spending are expanding access to urology treatments, creating opportunities for device manufacturers to penetrate tier-2 and tier-3 markets across India.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | URINARY INCONTINENCE (UI) (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 34.57 (2025) |
| Revenue Forecast (Billions) | ~USD 46.26 (2030) |
| Segments Covered | Product, Type, Application, End User |
4 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 29.2 | 30.2 | 31.3 | 33.1 | 35.3 | 38 | 41.1 | 45.4 | 7.7 |
| CLINICS | 13.6 | 13.9 | 14.4 | 15.1 | 16 | 17.1 | 18.4 | 20.2 | 7 |
| DIALYSIS CENTERS | 123.7 | 130.4 | 137.6 | 148.2 | 160.8 | 176 | 194.2 | 218.2 | 9.7 |
| HOME CARE SETTINGS | 91.7 | 96.2 | 100.9 | 108.1 | 116.8 | 170.8 | 182.3 | 197.9 | 14.4 |
| HOSPITALS | 488.4 | 508.5 | 529.7 | 563.2 | 603.3 | 608.2 | 667.8 | 746 | 7.1 |
| TOTAL | 746.6 | 779.2 | 813.9 | 867.7 | 932.2 | 1010.1 | 1103.8 | 1227.7 | 8.6 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| SIEMENS HEALTHINEERS | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| NOVANTA, INC | United States | Public Company | Precision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration), |
| LUMENIS LTD | Israel | Private Company | Surgical,Ophthalmic,Aesthetic, |
| MERIT MEDICAL | United States | Public Company | Cardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits), |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Germany | Public Company | Care Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| B. BRAUN MELSUNGEN AG | Germany | Private Company | Infusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions, |
| CARDINAL HEALTH | United States | Public Company | Branded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services, |
| INTUITIVE SURGICAL | United States | Public Company | da Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories, |
| COLOPLAST A/S | Denmark | Public Company | Ostomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel), |
| STRYKER | United States | Public Company | Orthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures), |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS), |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Advanced Wound Care,Ostomy Care,Continence Care, |
| MEDTRONIC PLC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.
Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.
Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.
Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.
Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.
B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.
Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.
Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.
Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.
Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.
Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.
ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.
Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.
India's urology devices market is valued at USD 813.9 million in 2025 and is projected to reach USD 1,227.7 million by 2030.
India's urology devices market is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.
Key drivers include rising prevalence of urological disorders, increasing healthcare expenditure, aging population demographics, adoption of minimally invasive procedures, and government healthcare modernization initiatives in India.
India's market is growing at 8.6% CAGR, which exceeds the global average of 6% CAGR, positioning India as a high-growth market within the Asia Pacific region.
Stone management systems, endoscopic instruments, and catheter-based solutions are experiencing accelerated adoption across India's healthcare facilities between 2025 and 2030.
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.
To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Full forecast, segment splits, and company analysis for all Urology Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report